Sterling Capital Management’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $10.5M | Sell |
35,934
-70,173
| -66% | -$23.1M | 0.2% | 92 |
|
|
2025
Q4 | $37.2M | Sell |
106,107
-71,337
| -40% | -$24.1M | 0.6% | 36 |
|
|
2025
Q3 | $57.3M | Sell |
177,444
-18,531
| -9% | -$5.76M | 0.84% | 34 |
|
|
2025
Q2 | $76.2M | Sell |
195,975
-114,471
| -37% | -$46M | 1.08% | 24 |
|
|
2025
Q1 | $135M | Sell |
310,446
-6,343
| -2% | -$2.55M | 2.09% | 7 |
|
|
2024
Q4 | $117M | Buy |
316,789
+17,813
| +6% | +$7.45M | 1.6% | 12 |
|
|
2024
Q3 | $155M | Buy |
+298,976
| New | +$160M | 2.01% | 7 |
|
|
2019
Q3 | $64.9M | Sell |
270,361
-14,765
| -5% | -$4.05M | 0.62% | 63 |
|
|
2019
Q2 | $80.5M | Buy |
285,126
+81,933
| +40% | +$22.4M | 0.78% | 39 |
|
|
2019
Q1 | $58.3M | Buy |
203,193
+5,203
| +3% | +$1.5M | 0.58% | 69 |
|
|
2018
Q4 | $52M | Sell |
197,990
-73,583
| -27% | -$20.2M | 0.56% | 68 |
|
|
2018
Q3 | $74.4M | Sell |
271,573
-32,095
| -11% | -$8.33M | 0.67% | 50 |
|
|
2018
Q2 | $72.3M | Sell |
303,668
-9,917
| -3% | -$2.3M | 0.67% | 55 |
|
|
2018
Q1 | $68.9M | Sell |
313,585
-52,588
| -14% | -$12.4M | 0.65% | 59 |
|
|
2017
Q4 | $82.4M | Sell |
366,173
-97,631
| -21% | -$20.8M | 0.75% | 41 |
|
|
2017
Q3 | $88.1M | Sell |
463,804
-21,171
| -4% | -$4.03M | 0.83% | 34 |
|
|
2017
Q2 | $91.2M | Sell |
484,975
-114,776
| -19% | -$20.6M | 0.88% | 30 |
|
|
2017
Q1 | $99.2M | Sell |
599,751
-205,174
| -25% | -$32.6M | 0.93% | 28 |
|
|
2016
Q4 | $116M | Buy |
804,925
+31,184
| +4% | +$4.18M | 1.04% | 17 |
|
|
2016
Q3 | $97M | Buy |
773,741
+45,442
| +6% | +$5.87M | 0.89% | 33 |
|
|
2016
Q2 | $95.7M | Buy |
728,299
+13,782
| +2% | +$1.89M | 0.87% | 27 |
|
|
2016
Q1 | $99.3M | Sell |
714,517
-23,590
| -3% | -$3.15M | 0.9% | 22 |
|
|
2015
Q4 | $103M | Buy |
738,107
+37,305
| +5% | +$5.14M | 0.91% | 23 |
|
|
2015
Q3 | $98.1M | Sell |
700,802
-8,258
| -1% | -$1.24M | 0.88% | 29 |
|
|
2015
Q2 | $116M | Sell |
709,060
-727,065
| -51% | -$116M | 1.05% | 21 |
|
|
2015
Q1 | $222M | Sell |
1,436,125
-316,761
| -18% | -$45.1M | 1.98% | 4 |
|
|
2014
Q4 | $220M | Buy |
1,752,886
+314,970
| +22% | +$38.9M | 1.92% | 3 |
|
|
2014
Q3 | $172M | Sell |
1,437,916
-747,930
| -34% | -$85.8M | 2.09% | 3 |
|
|
2014
Q2 | $235M | Sell |
2,185,846
-28,291
| -1% | -$2.92M | 2.03% | 2 |
|
|
2014
Q1 | $220M | Buy |
2,214,137
+28,773
| +1% | +$2.6M | 1.88% | 3 |
|
|
2013
Q4 | $202M | Buy |
2,185,364
+79,409
| +4% | +$7.06M | 1.85% | 3 |
|
|
2013
Q3 | $176M | Buy |
2,105,955
+50,746
| +2% | +$4.35M | 2.07% | 2 |
|
|
2013
Q2 | $168M | Buy |
+2,055,209
| New | +$154M | 2.07% | 2 |
|
Other funds holding ELV
VCM
VPM
Sterling Capital Management's ELV Position: Q1 2026 in Review
Sterling Capital Management reduced its Elevance Health (ELV) stake by 66% in Q1 2026, selling an estimated $23.1M and leaving 35,934 shares worth $10.5M. The position accounts for 0.2% of the portfolio, ranked #92.
Sterling Capital Management first reported a position in ELV in Q2 2013 and has held it in 33 quarters since. The position peaked at $235M in Q2 2014. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.
- Sterling Capital Management held 35,934 shares of Elevance Health worth $10.5M as of Q1 2026.
- Sterling Capital Management sold 70,173 Elevance Health shares in Q1 2026, an estimated $23.1M.
- Elevance Health made up 0.2% of Sterling Capital Management's portfolio in Q1 2026, its #92 holding.
- Sterling Capital Management first reported a position in Elevance Health in Q2 2013 and has held it in 33 quarters since.
- Sterling Capital Management's Elevance Health position peaked at $235M in Q2 2014.
- 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.
Based on Sterling Capital Management's 13F filing for Q1 2026, filed 22 Apr 2026.